(Circulation. 1997;95:169-175.)
© 1997 American Heart Association, Inc.
Articles |
Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure
the Departments of Cardiology (B.R.) and Clinical Physiology (P.F.), Heart and Lung Institute, and the Department of Clinical Neurophysiology (M.E., Y.B.-S.), Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Goteborg, Sweden; and the Clinical Neuroscience Branch (G.E.), National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.
Correspondence to Bengt Rundqvist, MD, PhD, Department of Cardiology, Sahlgrenska University Hospital, S-413 45 Goteborg, Sweden. E-mail bengtr@wlab.wall.gu.se.
Background Previous studies with radiotracer methods have indicated increases in cardiac norepinephrine (NE) and renal NE spillover in patients with severe congestive heart failure (CHF). However, data on the regional sympathetic profile in early stages of CHF are limited. In this study, sympathetic function in the heart, kidneys, and skeletal muscle was evaluated in patients with mild-to-moderate CHF and compared with that in patients with severe CHF and healthy subjects.
Methods and Results Total body and regional NE spillover from the heart and kidney was assessed with isotope dilution with steady state infusions of [3H]NE. Sympathetic nerve traffic to the skeletal muscle vascular bed (MSA) was recorded intraneurally. Cardiac NE spillover in patients with mild-to-moderate CHF (n=21) was increased threefold versus that in healthy subjects (n=12, P<.05), whereas total body and renal NE spillover and MSA did not differ from those in healthy subjects. In the severe CHF group (n=12), cardiac NE spillover was increased fourfold (P<.05), and total body and renal NE spillover and MSA were high compared with both mild-to-moderate CHF subjects and healthy subjects (P<.05 for both). Fractional extraction of [3H]NE across the heart was reduced by 
40% in both CHF groups versus control subjects (P<.05).
Conclusions These results indicate a selective increase in cardiac adrenergic drive (increased amounts of transmitter available at neuroeffector junctions) in patients with mild-to-moderate CHF. This increase appears to precede the augmented sympathetic outflow to the kidneys and skeletal muscle found in advanced CHF.
Key Words: norepinephrine • heart failure • nervous system, autonomic
This article has been cited by other articles:
 |
|
 |
|
  V. R. S. Fernandes, K. C. Wu, B. D. Rosen, A. Schmidt, A. C. Lardo, N. Osman, H. R. Halperin, G. Tomaselli, R. Berger, D. A. Bluemke, et al. Enhanced Infarct Border Zone Function and Altered Mechanical Activation Predict Inducibility of Monomorphic Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy Radiology, December 1, 2007; 245(3): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. D. Watson, S. G. Hood, R. Ramchandra, R. M. McAllen, and C. N. May Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H798 - H804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Hesayen and J. D. Parker Adverse effects of atrioventricular synchronous right ventricular pacing on left ventricular sympathetic activity, efficiency, and hemodynamic status Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2377 - H2379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Floras Atrial fibrillation and cardiac sympathetic reflexes in heart failure Eur. Heart J., December 1, 2005; 26(23): 2490 - 2492. [Full Text] [PDF]
|
|
|
|
|
|
J. Spaak, Z. J. Egri, T. Kubo, E. Yu, S.-I. Ando, Y. Kaneko, K. Usui, T. D. Bradley, and J. S. Floras Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea Hypertension, December 1, 2005; 46(6): 1327 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Munch, K. Rosport, A. Bultmann, C. Baumgartner, Z. Li, L. Laacke, and M. Ungerer Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure Circ. Res., October 28, 2005; 97(9): 928 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Jardine, C. J. Charles, R. K. Ashton, S. I. Bennett, M. Whitehead, C. M. Frampton, and M. G. Nicholls Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model J. Physiol., May 15, 2005; 565(1): 325 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Petersson, P. Friberg, G. Eisenhofer, G. Lambert, and B. Rundqvist Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure Eur. Heart J., May 1, 2005; 26(9): 906 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kaye and M. Esler Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res, May 1, 2005; 66(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. McBride and C. M. White Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kaye, B. Smirk, S. Finch, C. Williams, and M. D. Esler Interaction between cardiac sympathetic drive and heart rate in heart failure: Modulation by adrenergic receptor genotype J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2008 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P Frenneaux Autonomic changes in patients with heart failure and in post-myocardial infarction patients Heart, November 1, 2004; 90(11): 1248 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.R. Bristow, H. Krause-Steinrauf, R. Nuzzo, C.-S. Liang, J. Lindenfeld, B.D. Lowes, B. Hattler, W.T. Abraham, L. Olson, S. Krueger, et al. Effect of Baseline or Changes in Adrenergic Activity on Clinical Outcomes in the {beta}-Blocker Evaluation of Survival Trial Circulation, September 14, 2004; 110(11): 1437 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Eisenhofer, I. J. Kopin, and D. S. Goldstein Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine Pharmacol. Rev., September 1, 2004; 56(3): 331 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. D. Watson, R. Mogulkoc, R. M. McAllen, and C. N. May Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1051 - R1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, B. S. Huang, D. Ganten, and F. H.H. Leenen Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in Transgenic Rats Deficient in Brain Angiotensinogen Circ. Res., April 2, 2004; 94(6): 843 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Modesti, G Polidori, I Bertolozzi, S Vanni, and I Cecioni Impairment of cardiopulmonary receptor sensitivity in the early phase of heart failure Heart, January 1, 2004; 90(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sato, K. Maehara, H. Yaoita, H. Otani, A. Hirosaka, T. Saito, N. Onuki, N. Komatsu, T. Ishihata, and Y. Maruyama Correlation Between Cardiac Norepinephrine Overflow During Exercise and Cardiac 123I-MIBG Uptake in Patients with Chronic Heart Failure J. Nucl. Med., October 1, 2003; 44(10): 1618 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hata and W. J. Koch Phosphorylation of G Protein-Coupled Receptors: GPCR Kinases in Heart Disease Mol. Interv., August 1, 2003; 3(5): 264 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Kearney, K. A. A. Fox, A. J. Lee, R. J. Prescott, A. M. Shah, P. D. Batin, W. Baig, S. Lindsay, T. S. Callahan, W. E. Shell, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldstein, D. Robertson, M. Esler, S. E. Straus, and G. Eisenhofer Dysautonomias: Clinical Disorders of the Autonomic Nervous System Ann Intern Med, November 5, 2002; 137(9): 753 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.M. Kaye Alterations in oxygen consumption and sympathetic nervous activity in heart failure: independent or associated mechanisms? Eur. Heart J., May 2, 2002; 23(10): 764 - 766. [Full Text] [PDF]
|
|
|
|
|
|
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure Eur. Heart J., May 2, 2002; 23(10): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Foody, M. H. Farrell, and H. M. Krumholz {beta}-Blocker Therapy in Heart Failure: Scientific Review JAMA, February 20, 2002; 287(7): 883 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Jardine, C. J. Charles, I. C. Melton, C. N. May, M. D. Forrester, C. M. Frampton, S. I. Bennett, and H. Ikram Continual recordings of cardiac sympathetic nerve activity in conscious sheep Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H93 - H99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malliani and N. Montano Emerging Excitatory Role of Cardiovascular Sympathetic Afferents in Pathophysiological Conditions Hypertension, January 1, 2002; 39(1): 63 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B Haitsma, D. Bac, N. Raja, F. Boomsma, P. D Verdouw, and D. J Duncker Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations Cardiovasc Res, December 1, 2001; 52(3): 417 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L'Abbate and G. Sambuceti Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy Eur. Heart J., September 1, 2001; 22(17): 1521 - 1522. [PDF]
|
|
|
|
|
|
H. Kubo, K. B. Margulies, V. Piacentino III, J. P. Gaughan, and S. R. Houser Patients With End-Stage Congestive Heart Failure Treated With {beta}-Adrenergic Receptor Antagonists Have Improved Ventricular Myocyte Calcium Regulatory Protein Abundance Circulation, August 28, 2001; 104(9): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats Hypertension, August 1, 2001; 38(2): 255 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.P Brunner-La Rocca, M.D Esler, G.L Jennings, and D.M Kaye Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure Eur. Heart J., July 1, 2001; 22(13): 1136 - 1143. [Abstract] [PDF]
|
|
|
|
|
|
H. P. Brunner-La Rocca, D. M. Kaye, R. L. Woods, J. Hastings, and M. D. Esler Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1221 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Notarius, D. J. Atchison, and J. S. Floras Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H969 - H976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Notarius and J. S. Floras Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure Europace, January 1, 2001; 3(1): 29 - 38. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Omerovic, E. Bollano, R. Mobini, V. Kujacic, B. Madhu, B. Soussi, M. Fu, A. Hjalmarson, F. Waagstein, and J. Isgaard Growth Hormone Improves Bioenergetics and Decreases Catecholamines in Postinfarct Rat Hearts Endocrinology, December 1, 2000; 141(12): 4592 - 4599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. B. Sverrisdottir, B. Rundqvist, G. Johannsson, and M. Elam Sympathetic Neural Burst Amplitude Distribution : A More Specific Indicator of Sympathoexcitation in Human Heart Failure Circulation, October 24, 2000; 102(17): 2076 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Azevedo, G. E. Newton, J. S. Floras, and J. D. Parker Reducing Cardiac Filling Pressure Lowers Norepinephrine Spillover in Patients With Chronic Heart Failure Circulation, May 2, 2000; 101(17): 2053 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, G. Vaddadi, S. L. Gruskin, X.-J. Du, and M. D. Esler Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure Circ. Res., April 14, 2000; 86 (7): e80 - e84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Patel, K. Zhang, and P. K. Carmines Norepinephrine turnover in peripheral tissues of rats with heart failure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R556 - R562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. H. Leenen, B. Yuan, and B. S. Huang Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1786 - H1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Macefield, B. Rundqvist, Y. B. Sverrisdottir, B. G. Wallin, and M. Elam Firing Properties of Single Muscle Vasoconstrictor Neurons in the Sympathoexcitation Associated With Congestive Heart Failure Circulation, October 19, 1999; 100(16): 1708 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, T.-H. M. Fan, E. Dong, R. A. Siddiqui, A. Yatani, S. Y. Stevens, and C.-S. Liang ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1609 - H1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, A. M. Dart, G. L. Jennings, and M. D. Esler Antiadrenergic effect of chronic amiodarone therapy in human heart failure J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1553 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, B. S. Huang, and F. H. H. Leenen Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1608 - H1615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Abramson, S.-i. Ando, C. F. Notarius, G. A. Rongen, and J. S. Floras Effect of Atrial Natriuretic Peptide on Muscle Sympathetic Activity and Its Reflex Control in Human Heart Failure Circulation, April 13, 1999; 99(14): 1810 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Exner, D. L. Dries, M. A. Waclawiw, B. Shelton, and M. J. Domanski Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction J. Am. Coll. Cardiol., March 15, 1999; 33(4): 916 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Hartmann, S Ziegler, S Nekolla, M Hadamitzky, M Seyfarth, G Richardt, and M Schwaiger Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography Heart, March 1, 1999; 81(3): 262 - 270. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Richards, R. Doughty, M. G. Nicholls, S. Macmahon, H. Ikram, N. Sharpe, E. A. Espiner, C. Frampton, and T. G. Yandle Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction Circulation, February 16, 1999; 99(6): 786 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Lohmeier, G. A. Reinhart, H. L. Mizelle, M. Han, and M. M. Dean Renal denervation supersensitivity revisited Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1239 - R1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Abraham Pharmacologic Management of Chronic Heart Failure: A Review Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190. [Abstract] [PDF]
|
|
|
|
|
|
G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nozawa, A. Igawa, N. Yoshida, M. Maeda, M. Inoue, Y. Yamamura, H. Asanoi, and H. Inoue Dual-Tracer Assessment of Coupling Between Cardiac Sympathetic Neuronal Function and Downregulation of ß-Receptors During Development of Hypertensive Heart Failure of Rats Circulation, June 16, 1998; 97(23): 2359 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ungerer, F. Hartmann, M. Karoglan, A. Chlistalla, S. Ziegler, G. Richardt, M. Overbeck, H. Meisner, A. Schomig, and M. Schwaiger Regional In Vivo and In Vitro Characterization of Autonomic Innervation in Cardiomyopathic Human Heart Circulation, January 20, 1998; 97(2): 174 - 180. [Abstract] [Full Text] [PDF]
|
|